JP2009513568A5 - - Google Patents

Download PDF

Info

Publication number
JP2009513568A5
JP2009513568A5 JP2008532507A JP2008532507A JP2009513568A5 JP 2009513568 A5 JP2009513568 A5 JP 2009513568A5 JP 2008532507 A JP2008532507 A JP 2008532507A JP 2008532507 A JP2008532507 A JP 2008532507A JP 2009513568 A5 JP2009513568 A5 JP 2009513568A5
Authority
JP
Japan
Prior art keywords
radionuclide
substance
composition
collagen
antibody
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2008532507A
Other languages
English (en)
Japanese (ja)
Other versions
JP2009513568A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2006/037764 external-priority patent/WO2007038641A2/en
Publication of JP2009513568A publication Critical patent/JP2009513568A/ja
Publication of JP2009513568A5 publication Critical patent/JP2009513568A5/ja
Pending legal-status Critical Current

Links

JP2008532507A 2005-09-26 2006-09-26 コラーゲン曝露を伴う炎症状態の処置のための方法と治療剤 Pending JP2009513568A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US72078805P 2005-09-26 2005-09-26
PCT/US2006/037764 WO2007038641A2 (en) 2005-09-26 2006-09-26 Methods and therapies for treating inflammatory conditions with exposed collagen

Publications (2)

Publication Number Publication Date
JP2009513568A JP2009513568A (ja) 2009-04-02
JP2009513568A5 true JP2009513568A5 (enExample) 2009-10-22

Family

ID=37900444

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2008532507A Pending JP2009513568A (ja) 2005-09-26 2006-09-26 コラーゲン曝露を伴う炎症状態の処置のための方法と治療剤

Country Status (5)

Country Link
US (1) US9623129B2 (enExample)
EP (1) EP2341945A2 (enExample)
JP (1) JP2009513568A (enExample)
CA (1) CA2623554C (enExample)
WO (1) WO2007038641A2 (enExample)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8114264B2 (en) * 2005-02-10 2012-02-14 Brookhaven Science Associates Method of electroplating a conversion electron emitting source on implant
US8834338B2 (en) * 2005-02-10 2014-09-16 Snip Holdings, Inc. Dosimetry implant for treating restenosis and hyperplasia
US8257681B2 (en) 2008-12-26 2012-09-04 Clear Vascular Inc. Compositions of high specific activity SN-117M and methods of preparing the same
US10772931B2 (en) 2014-04-25 2020-09-15 Purdue Research Foundation Collagen binding synthetic peptidoglycans for treatment of endothelial dysfunction
NZ771201A (en) 2017-04-06 2025-01-31 Sustain Holdings Llc Collagen Peptide-Based Medicament Compositions And Devices And Methods Of Production And Use Thereof
WO2019169241A1 (en) * 2018-03-02 2019-09-06 Serene, Llc Methods of treating and imaging ungulate laminitis
PT3958889T (pt) 2019-04-22 2025-04-10 Sustain Holdings Llc Composições de péptidos miméticos de colagénio para o tratamento de uma doença ou perturbação ocular so segmento posterior que envolve a retina, os vasos sanguíneos da retina, os nervos retinianos ou o nervo ótico

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4647445A (en) 1984-03-28 1987-03-03 Massachusetts Institute Of Technology Radiolabelled lipoproteins and method for making same
US4937067A (en) 1984-12-13 1990-06-26 Massachusetts Institute Of Technology Method and means for detection of adrenal metabolic activity
US4660563A (en) 1984-12-31 1987-04-28 Massachusetts Institute Of Technology Method and means for detection of arterial lesions
US5225181A (en) 1985-06-07 1993-07-06 The Research Foundation Of State University Of New York Radiolabeled antiplatelet monoclonal antibody for imaging in-vivo thrombi
US4877599A (en) 1986-11-10 1989-10-31 New England Deaconess Hospital Corporation Detection of vascular disease with labelled antibodies
US5726153A (en) * 1988-05-02 1998-03-10 New England Deaconess Hospital Corporation Synthetic peptides for arterial imaging
AU628357B2 (en) 1988-05-02 1992-09-17 New England Deaconess Hospital Corporation Synthetic peptides for arterial imaging
CA1340977C (en) 1988-11-15 2000-04-25 Monty Krieger Scavenger receptor protein and antibody thereto
US5334729A (en) 1989-06-29 1994-08-02 Associated Universities, Inc. Stable radiometal antibody immunoconjugates
US7238340B1 (en) * 1991-11-27 2007-07-03 Cis Bio International Monoamine, diamide, thiol-containing metal chelating agents
ATE237365T1 (de) 1992-03-13 2003-05-15 Diatide Inc Technetium-99-markierte peptide zur visualisierung vom entzuendungen
US5292938A (en) 1992-04-13 1994-03-08 Associated Universities, Inc. Synthesis of 4-substituted-trans-1, 2-diaminocyclohexyl polyaminocarboxylate metal chelating agents for the preparation of stable radiometal antibody immunoconjugates for therapy and spect and pet imaging
US5429133A (en) 1992-12-18 1995-07-04 Neoprobe Corporation Radiation responsive laparoscopic instrument
US5428156A (en) 1993-04-02 1995-06-27 Associated Universities, Inc. Synthesis of macrocyclic polyaminocarboxylates and their use for preparing stable radiometal antibody immunoconjugates for therapy, spect and pet imaging
US5968477A (en) 1994-01-24 1999-10-19 Neorx Corporation Radiolabeled annexin conjugates with hexose and a chelator
US5783169A (en) 1995-07-26 1998-07-21 Brookhaven Science Associates Llc Rigid bifunctional chelating agents
US5811814A (en) 1996-02-12 1998-09-22 Cordis Corporation Radiation measuring catheter apparatus and method
HUP0001261A3 (en) 1997-04-30 2001-11-28 Univ Washington Seattle Method of imaging cell death in vivo
JP2004510830A (ja) * 2000-10-11 2004-04-08 ターゲサム・インコーポレーテッド 標的化された治療用薬剤
US20030152513A1 (en) 2001-09-06 2003-08-14 Imetrix, Inc. Intravascular delivery of therapeutic and imaging agents to stressed and apoptotic cells using annexin V as a targeting vector
ATE411819T1 (de) * 2003-02-17 2008-11-15 Upperton Ltd Konjugate für medizinische abbildungen umfassend träger, targeting-anteile und kontrastmittel

Similar Documents

Publication Publication Date Title
JP2012509886A5 (enExample)
JP2006506333A5 (enExample)
JP2007051159A5 (enExample)
IL186671A (en) Monoclonal antibodies that bind specifically to the amyloid-cell peptide, methods of making them, pharmaceutical preparations that include them and their use in the manufacture of drugs
EA201100694A1 (ru) Антитело к cd38 человека и его применение
IL198870A0 (en) ANTIBODIES THAT BIND TO HUMAN PDGFRa AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME
FI3569620T3 (fi) Ihmisen cgrp-reseptoria sitovat vasta-aineet
JP2010522208A5 (enExample)
JP2007510639A5 (enExample)
UA109633C2 (uk) Антитіло людини проти тканинного фактора
HRP20170882T1 (hr) Humani antigen-vezujući proteini koji se vežu za beta-klotho, fgf receptore i njihove komplekse
RU2015114990A (ru) Способы, композиции и приборы для облегчения регенерации
JP2007520566A5 (enExample)
GB2414732A (en) Human antibodies specific for interleukin 15 (IL-15)
EA200800696A1 (ru) Полипептиды и антитела
EA200801509A1 (ru) Человеческие моноклональные антитела к протеинтирозинкиназе 7 ( ptk7) и способы применения антител против ptk7
JP2014512812A5 (enExample)
SG153825A1 (en) Multivalent immunoglobulin-based bioactive assemblies
CN111246886A (zh) 一种抗pd-l1人源化单克隆抗体的药物组合物
JP2011502137A5 (enExample)
JP2009513568A5 (enExample)
JP2013520996A5 (enExample)
WO2008146165A3 (en) Kit of parts for the treatment of cancer or infectious diseases
JP2004510683A5 (enExample)
JP2012131808A5 (enExample)